Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - The Swedish AMORIS study

European Journal of Cancer

Volumn 47, Issue 13, 2011, Pages 2033-2041

  Van Hemelrijck, Mieke ^a   Jassem, Wayel ^b   Walldius, Goran ^c   Fentiman, Ian S ^d   Hammar, Niklas ^c,e   Lambe, Mats ^c,f   Garmo, Hans ^a,f   Jungner, Ingmar ^c,g   Holmberg, Lars ^a,e  

^a GUY S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e ASTRAZENECA R AND D   (Sweden)

^f UPPSALA UNIVERSITY   (Sweden)

^g CALAB Research   (Sweden)

Author keywords

Cancer; Gamma glutamyltransferase; Glucose; Sweden

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; FEMALE; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SEX DIFFERENCE;

ADULT; COHORT STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTORS; SWEDEN; YOUNG ADULT;

EID: 80051874500     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.03.010     Document Type: Article

References (31)

1. G. Targher Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative review Clin Chem Lab Med 48 2 2010 147 157
2. A.M. Strasak, G. Goebel, and H. Concin Prospective study of the association of serum gamma-glutamyltransferase with cervical intraepithelial neoplasia III and invasive cervical cancer Cancer Res 70 9 2010 3586 3593
3. A.M. Strasak, R.M. Pfeiffer, and J. Klenk Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women Int J Cancer 123 8 2008 1902 1906
4. A.M. Strasak, K. Rapp, and L.J. Brant Association of gamma- glutamyltransferase and risk of cancer incidence in men: a prospective study Cancer Res 68 10 2008 3970 3977
5. Choi J, Liu RM, Forman HJ. Adaptation to oxidative stress: quinone-mediated protection of signaling in rat lung epithelial L2 cells. Biochem Pharmacol 1997;53(7):987-93. Available from http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids= 9174112. (Pubitemid 27224279)
6. Fentiman IS, Allen DS. gamma-Glutamyl transferase and breast cancer risk. Br J Cancer 2010;103(1):90-3. Available from http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids= 20517309.
7. Brownlee M. Negative consequences of glycation. Metabolism 2000;49(2 Suppl 1):9-13. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list-uids=10693913. (Pubitemid 30091786)
8. G. Walldius, I. Jungner, and I. Holme High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study Lancet 358 9298 2001 2026 2033 (Pubitemid 34084825)
9. Jungner I, Marcovina SM, Walldius G, et al. Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization - International Federation of Clinical Chemistry First International Reference Materials. Clin Chem 1998;44(8 Pt 1):1641-9. (Pubitemid 28381205)
10. I. Holme, A.H. Aastveit, I. Jungner, and G. Walldius Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS) J Intern Med 264 1 2008 30 38 (Pubitemid 351813479)
11. I. Holme, A.H. Aastveit, N. Hammar, I. Jungner, and G. Walldius Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS) J Intern Med 265 2 2009 275 287
12. G. Walldius, I. Jungner, W. Kolar, I. Holme, and E. Steiner High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study Blood Press Suppl 4 1992 35 42
13. Van Hemelrijck M, Garmo H, Binda E, et al. Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study. Cancer Causes Control 2010.
14. Van Hemelrijck M, Garmo H, Holmberg L, et al. Prostate cancer risk in the Swedish AMORIS study: The interplay between triglycerides, total cholesterol, and glucose. Cancer 2010; in press.
15. Central Bureau for Statistics. Statistics Sweden Stockholm, Sweden, 2008.
16. I. Jungner, G. Walldius, I. Holme, W. Kolar, and E. Steiner Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43, 000 Swedish males and females Int J Clin Lab Res 21 3 1992 247 255
17. Proctor MJ, Talwar D, Balmar SM, et al. The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. Br J Cancer 2010;103(6):870-6. Available from http://www.ncbi.nlm.nih. gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list- uids=20717110.
18. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.
19. H.B. El-Serag, H. Hampel, and F. Javadi The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence Clin Gastroenterol Hepatol 4 3 2006 369 380 (Pubitemid 43343895)
20. A. Esfahani, J.M. Wong, and A. Mirrahimi The glycemic index: physiological significance J Am Coll Nutr 28 Suppl 2009 439S 445S
21. M. Saruc, and P.M. Pour Diabetes and its relationship to pancreatic carcinoma Pancreas 26 4 2003 381 387 (Pubitemid 36529965)
22. Forman HJ, Azzi A. On the virtual existence of superoxide anions in mitochondria: thoughts regarding its role in pathophysiology. FASEB J 1997;11(5):374-5. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi? cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=9141504.
23. Rajpert-De Meyts E, Shi M, Chang M, et al. Transfection with gamma-glutamyl transpeptidase enhances recovery from glutathione depletion using extracellular glutathione. Toxicol Appl Pharmacol 1992;114(1):56-62. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=1350117.
24. Dominici S, Paolicchi A, Corti A, Maellaro E, Pompella A. Prooxidant reactions promoted by soluble and cell-bound gamma-glutamyltransferase activity. Methods Enzymol 2005;401:484-501. Available from http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids= 16399404. (Pubitemid 43052409)
25. Braun L, Goyette M, Yaswen P, Thompson NL, Fausto N. Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats. Cancer Res 1987;47(15):4116-24. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=2440558. (Pubitemid 17108480)
26. Hanigan MH, Gallagher BC, Townsend DM, Gabarra V. Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo. Carcinogenesis 1999;20(4):553-9. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=10223181. (Pubitemid 29151289)
27. B.A. Calton, S.C. Chang, and M.E. Wright History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study Cancer Causes Control 18 5 2007 493 503 (Pubitemid 46684823)
28. Stocks T, Rapp K, Bjorge T, et al. Blood glucose and risk of incident and fatal cancer in the metabolic -syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med 2009;6(12):e1000201. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=20027213.
29. Nishikawa T, Edelstein D, Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl 2000;77:S26-30. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list-uids=10997687.
30. Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ 2005;172(3):367-79. Available from http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids= 15684121.
31. Holzmann M, Jungner I, Walldius G, et al. Apolipoproteins B and A-I, standard lipid measures and incidence of myocardial infarction in men and women, with or without chronic kidney disease. Study IV in Thesis for doctorial degree (PhD). In: Holzmann M, editor. Renal insufficiency, mortality and myocardial infarction Stockholm: Karolinska Institute, 2008.